查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030年全球口腔癌快速检测试剂盒市场
市场调查报告书
商品编码
1296876

2023-2030年全球口腔癌快速检测试剂盒市场

Global Oral Cancer Rapid Test Kit Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

在预测期内，全球口腔癌快速检测试剂盒市场预计将以4.1%的可观复合增长率增长。市场的增长归因于口腔癌发病率的增加和早期检测的需要等因素。技术的进一步进步和研发投资的增加，也有望推动对口腔癌快速检测试剂盒的需求。例如，在2020年10月，Sascan Meditech推出了名为OralScan的手持式口腔癌筛查设备。该设备旨在为口腔癌提供有效的筛查解决方案，实现早期检测和及时干预。这一发展凸显了在医疗技术和癌症筛查领域的努力和进步。

分段展望

全球口腔癌快速检测试剂盒市场是根据其类型和应用来分類的。基于类型，市场被细分为onc alert口腔癌实验室、芯片上的实验室、insilixa测试和prevo-check。基于应用，市场被分为医院、诊断中心和研究中心。在应用部分，由于癌症专科医院的发展，医院子部分预计将占据市场的突出份额。

预测期内，芯片实验室子领域将出现可观的市场增长

目录

第一章：报告摘要

  • 当前行业分析和增长潜力展望
  • 研究方法和工具
  • 市场细分
    • 按领域划分
    • 按地区

第二章：市场概述和洞察力

  • 报告的范围
  • 分析师的洞察力和当前的市场趋势
    • 主要发现
    • 建议
    • 总结

第三章：竞争格局

  • 主要公司分析
  • Abbott Laboratories
    • 概述
    • 财务分析
    • SWOT分析
    • 近期发展情况
  • F. Hoffmann-La Roche AG
    • 概况
    • 财务分析
    • SWOT分析
    • 近期发展情况
  • Thermo Fisher Scientific Inc.
    • 进展概况
    • 财务分析
    • SWOT分析
    • 近期发展
  • 关键战略分析

第四章：市场细分

  • 全球口腔癌快速检测试剂盒市场的类型
    • Onc Alert口腔癌实验室
    • 片上实验室
    • Insilixa测试
    • 预检
  • 全球口腔癌快速检测试剂盒市场的应用
    • 医院
    • 诊断中心
    • 研究中心

第五章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 意大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第六章：公司简介

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Co.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corp.
  • GRAIL, LLC
  • Henry Schein, Inc.
  • Quest Diagnostics
  • Quidel Corp.
  • Siemens Healthineers
  • Trinity Biotech plc
  • Viome Life Sciences, Inc.
  • Wantai BioPharm
Product Code: OMR2027371

Title: Global Oral Cancer Rapid Test Kit Market Size, Share & Trends Analysis Report by Type (Onc Alert Oral Cancer LAB, Lab on Chip, Insilixa Test, and Prevo-Check) and by Application (Hospitals, Diagnostic Center, and Research Centers) Forecast Period (2023-2030).

The global oral cancer rapid test kit market is anticipated to grow at a considerable CAGR of 4.1% during the forecast period. The growth of the market is attributed to factors such as increasing prevalence of oral cancer and the need for early detection. Further advancements in technology and rising investments in research and development are also expected to fuel the demand for oral cancer rapid test kits. For instance, in October 2020, Sascan Meditech launched handheld oral cancer screening device called OralScan. The device aims to provide an effective screening solution for oral cancer, allowing for early detection and timely intervention. This development highlights the efforts and advancements made in the field of healthcare technology and cancer screening.

Segmental Outlook

The global oral cancer rapid test kit market is segmented based on its type and application. Based on the type, the market is segmented into onc alert oral cancer lab, lab on chip, insilixa test, and prevo-check. Based on the application, the market is categorized into hospitals, diagnostic centers, and research centers. Among the application segment, the hospital sub-segment is anticipated to hold a prominent share of the market owing to the rise in development of cancer specialty hospital.

Lab on Chip Sub-Segment to Register Considerable Market Growth During the Forecast Period

Among the type segment, the lab on chip sub-segment is anticipated to register significant growth during the forecast period. The lab on chip technology offers miniaturized, portable, and rapid testing capabilities, making it highly suitable for point-of-care diagnostics. The growth of this sub-segment is attributed to factors owing to its convenience, accuracy, and cost-effectiveness. Over the past few years, lab on chip devices have gained popularity in various healthcare settings due to their ability to deliver quick and reliable results.

Regional Outlooks

The global oral cancer rapid test kit market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these regions, Europe is anticipated to hold a prominent market share due to the presence of well-established healthcare infrastructure and increased awareness about oral cancer screenings. However, the Asia-Pacific region is projected to experience considerable growth in the oral cancer rapid test kit market due to rising healthcare expenditure, increasing awareness campaigns, and growing government initiatives for early cancer detection.

Global Oral Cancer Rapid Test Kit Market Growth, by Region 2022-2030

Source: OMR Analysis

The North American Region is anticipated to Hold a Significant Share in the Global Oral cancer rapid test kit Market

Among these regions, the Asia-Pacific region is anticipated to hold a significant share in the global oral cancer rapid test kit market during the forecast period. The regional market growth is primarily driven by factors including the increasing prevalence of oral cancer and rising awareness about early detection and diagnosis. Additionally, there is a considerable increase in the introduction programmes launched by the government to propogate awareness about early diagnosis and its benefits in treating oral cancer. For instance, in April 2023, Punjab has launched a new initiative to screen patients for oral cancer in the public health institutions. As per the report oral cancer is the most prevalent cancer in men in the country and significant cases of the disease are diagnosed each year in the country.

Market Players Outlook

The major companies serving the global oral cancer rapid test kit market include Abbott Laboratories, Becton, Thermo Fisher Scientific Inc., Trinity Biotech plc, Viome Life Sciences, Inc., Wantai BioPharm, Quest Diagnostics, Siemens Healthineers. These market players are considerably contributing to the market growth by adopting various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in August 2022 Viome Life Sciences, a biotechnology company launched a diagnostic test for oral and throat cancer that uses mRNA technology and an AI-powered platform.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global oral cancer rapid test kit market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Laboratories
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. F. Hoffmann-La Roche AG
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Thermo Fisher Scientific Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Oral Cancer Rapid Test Kit Market by Type
    • 4.1.1. Onc Alert Oral Cancer LAB
    • 4.1.2. Lab on Chip
    • 4.1.3. Insilixa Test
    • 4.1.4. Prevo- Check
  • 4.2. Global Oral Cancer Rapid Test Kit Market by Application
    • 4.2.1. Hospitals
    • 4.2.2. Diagnostic Center
    • 4.2.3. Research Centers

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abbott Laboratories
  • 6.2. Thermo Fisher Scientific Inc.
  • 6.3. F. Hoffmann-La Roche AG
  • 6.4. Beckman Coulter, Inc.
  • 6.5. Becton, Dickinson and Co.
  • 6.6. Bio-Rad Laboratories, Inc.
  • 6.7. Danaher Corp.
  • 6.8. GRAIL, LLC
  • 6.9. Henry Schein, Inc.
  • 6.10. Quest Diagnostics
  • 6.11. Quidel Corp.
  • 6.12. Siemens Healthineers
  • 6.13. Trinity Biotech plc
  • 6.14. Viome Life Sciences, Inc.
  • 6.15. Wantai BioPharm

LIST OF TABLES

  • 1. GLOBAL ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL ONC ALERT ORAL CANCER LAB RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL LAB ON CHIP ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL ORAL CANCER INSILIXA RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL ORAL CANCER PREVO- CHECK RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 7. GLOBAL ORAL CANCER RAPID TEST KIT FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL ORAL CANCER RAPID TEST KIT FOR DIAGNOSTIC CENTER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL ORAL CANCER RAPID TEST KIT FOR RESEARCH CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 14. EUROPEAN ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. EUROPEAN ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 16. EUROPEAN ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 17. ASIA-PACIFIC ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. ASIA-PACIFIC ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 19. ASIA-PACIFIC ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 21. REST OF THE WORLD ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 22. REST OF THE WORLD ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ORAL CANCER RAPID TEST KIT MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL ONC ALERT ORAL CANCER LAB RAPID TEST KIT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL LAB ON CHIP ORAL CANCER RAPID TEST KIT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL ORAL CANCER INSILIXA RAPID TEST KIT MARKET SHARE REGION, 2022 VS 2030 (%)
  • 5. GLOBAL ORAL CANCER PREVO- CHECK RAPID TEST KIT MARKET SHARE REGION, 2022 VS 2030 (%)
  • 6. GLOBAL ORAL CANCER RAPID TEST KIT MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 7. GLOBAL ORAL CANCER RAPID TEST KIT FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL ORAL CANCER RAPID TEST KIT FOR DIAGNOSTIC CENTER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL ORAL CANCER RAPID TEST KIT FOR RESEARCH CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL ORAL CANCER RAPID TEST KIT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. US ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. CANADA ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. UK ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. FRANCE ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. GERMANY ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. ITALY ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. SPAIN ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. REST OF EUROPE ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. INDIA ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. CHINA ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. JAPAN ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. SOUTH KOREA ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF ASIA-PACIFIC ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF THE WORLD ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)